long intergenic non-protein coding RNA 2718Genealiases: []
Q-omics provides the consensus-scored LINC02718 profile across patient tissues and cancer cell-line models. LINC02718 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in BRCA. Among the 18 cancer types available for tumor–normal comparison, LINC02718 is differentially expressed in 10, with the highest sampling consensus in UCEC. Additionally, LINC02718 RNA expression shows 16,404 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight BRCA, UCEC, and THYM as cancer lineages where LINC02718 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02718 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02718 survival associations across molecular data types. LINC02718 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02718 RNA expression–survival associations across cancer types. High LINC02718 expression shows unfavorable associations in COAD, KIRC and PCPG, but favorable associations in BRCA, BLCA and KIRP. The BRCA Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify BRCA as the clearest survival context for LINC02718 RNA expression.
This table summarizes LINC02718 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in LUSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02718. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02718 shows lower tumor expression in UCEC, LUSC, BRCA and LUAD and higher tumor expression in THCA and COAD. The UCEC box plot shows higher LINC02718 RNA expression in normal versus tumor tissue (log2 FC = −0.531, t-test p < 0.001).
This table shows molecular features associated with LINC02718 in patient tissues and cancer cell lines. In patient samples, LINC02718 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
